Transcriptomics

Dataset Information

0

Paclitaxel resistance in isogenic PDX


ABSTRACT: Tumor heterogeneity and resistance to chemotherapy represents a significant challenge in the clinical management of triple negative breast cancer (TNBC). By dissecting molecular pathways associated with treatment resistance, we sought to define patient sub-groups and define actionable targets for next-line treatment. Bulk RNA sequencing were performed on isogenic patient-derived xenografts (PDX) representing paclitaxel-sensitive and -resistant tumors. Pathways identified as upregulated in the resistant model were further explored as targets in downstream approcaches, and their clinical relevance evaluated in publicly available clincial data.

ORGANISM(S): Homo sapiens

PROVIDER: GSE265955 | GEO | 2024/10/01

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA1105034 | ENA
2024-08-10 | GSE272834 | GEO
2019-05-31 | GSE131762 | GEO
2024-06-21 | GSE264630 | GEO
2015-12-10 | E-GEOD-54772 | biostudies-arrayexpress
2021-08-01 | GSE157715 | GEO
2019-10-18 | GSE139043 | GEO
2011-07-18 | E-GEOD-12791 | biostudies-arrayexpress
2017-01-26 | GSE86839 | GEO
2011-07-19 | GSE12791 | GEO